Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
11,304,470
-
Total 13F shares
-
493,468
-
Share change
-
+491,211
-
Total reported value
-
$385,113
-
Price per share
-
$0.78
-
Number of holders
-
31
-
Value change
-
+$383,312
-
Number of buys
-
29
-
Number of sells
-
1
Institutional Holders of CONDUIT PHARMACEUTICALS INC. - Common Stock (CDT) as of Q1 2025
As of 31 Mar 2025,
CONDUIT PHARMACEUTICALS INC. - Common Stock (CDT) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
493,468 shares.
The largest 10 holders included
AQR CAPITAL MANAGEMENT LLC, STATE STREET CORP, UBS Group AG, Vanguard Personalized Indexing Management, LLC, Squarepoint Ops LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, FMR LLC, GOLDMAN SACHS GROUP INC, and MORGAN STANLEY.
This page lists
31
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.